BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22926903)

  • 1. The impact of timeliness of care on survival in non-small cell lung cancer patients.
    Radzikowska E; Roszkowski-Śliż K; Głaz P
    Pneumonol Alergol Pol; 2012; 80(5):422-9. PubMed ID: 22926903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delays on survival in patients with lung carcinoma in Montenegro.
    Živković D
    Acta Clin Croat; 2014 Dec; 53(4):390-8. PubMed ID: 25868305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
    Vinod SK; Chandra A; Berthelsen A; Descallar J
    Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of delays in diagnosis and treatment on survival in small cell lung cancer patients.
    Radzikowska E; Roszkowski-Sliz K; Chabowski M; Glaz P
    Adv Exp Med Biol; 2013; 788():355-62. PubMed ID: 23835998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a lung cancer care coordination program on timeliness of care.
    Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
    Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delays in the diagnosis and treatment of non-small-cell lung cancer.
    Sulu E; Tasolar O; Berk Takir H; Yagci Tuncer L; Karakurt Z; Yilmaz A
    Tumori; 2011; 97(6):693-7. PubMed ID: 22322833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wait times in diagnostic evaluation and treatment for patients with stage III non-small cell lung cancer in British Columbia.
    Wai ES; Mackinnon M; Hooker R; Moccia P; Perry KR; Truong PT
    Am J Clin Oncol; 2012 Aug; 35(4):373-7. PubMed ID: 21422900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of patient's and doctor's delay in patients with pulmonary tuberculosis discovered by visiting doctors with symptoms in particular on doctor's delay].
    Sasaki Y; Yamagishi F; Yagi T; Yamatani H; Kuroda F; Shoda H
    Kekkaku; 2000 Sep; 75(9):527-32. PubMed ID: 11068369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study.
    Alexander M; Evans SM; Stirling RG; Wolfe R; Officer A; MacManus M; Solomon B; Burbury K; Ball D
    J Thorac Oncol; 2016 May; 11(5):748-757. PubMed ID: 26851495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lung cancer--diagnosis and therapy delay].
    Radzikowska E; Roszkowski K; Głaz P
    Pneumonol Alergol Pol; 2001; 69(11-12):600-10. PubMed ID: 12134435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of case findings in pulmonary tuberculosis patients].
    Sasaki Y
    Kekkaku; 2002 Sep; 77(9):621-5. PubMed ID: 12397711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation?
    de Dios NR; Sanz X; Foro P; Membrive I; Reig A; Ortiz A; Jiménez R; Algara M
    Clin Transl Oncol; 2017 Apr; 19(4):440-447. PubMed ID: 27553602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of delays on prognosis in patients with non-small cell lung cancer.
    Myrdal G; Lambe M; Hillerdal G; Lamberg K; Agustsson T; Ståhle E
    Thorax; 2004 Jan; 59(1):45-9. PubMed ID: 14694247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
    Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
    J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment delays in non-small cell lung cancer and their prognostic implications.
    Diaconescu R; Lafond C; Whittom R
    J Thorac Oncol; 2011 Jul; 6(7):1254-9. PubMed ID: 21610526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
    Berghmans T; Tragas G; Sculier JP
    Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.